These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 9850407

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ultrasonographical investigation of periportal fibrosis in children with Schistosoma mansoni infection: reversibility of morbidity seven months after treatment with praziquantel.
    Mohamed-Ali Q, Doehring-Schwerdtfeger E, Abdel-Rahim IM, Schlake J, Kardorff R, Franke D, Kaiser C, Elsheikh M, Abdalla M, Schafer P.
    Am J Trop Med Hyg; 1991 Apr; 44(4):444-51. PubMed ID: 1904198
    [Abstract] [Full Text] [Related]

  • 9. Factors controlling the effect of praziquantel on liver fibrosis in Schistosoma mansoni-infected patients.
    Rahoud SA, Mergani A, Khamis AH, Saeed OK, Mohamed-Ali Q, Dessein AJ, Elwali NE.
    FEMS Immunol Med Microbiol; 2010 Feb; 58(1):106-12. PubMed ID: 20030714
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Detection of early liver fibrosis in patients with intestinal schistosomiasis: sonographic and histologic findings in Schistosoma mansoni infection.
    Chiavaroli R, Grima P, Grima P.
    Infection; 2008 Dec; 36(6):585-9. PubMed ID: 18998054
    [Abstract] [Full Text] [Related]

  • 16. Hepatosplenic schistosomiasis: playing hide-and-seek with an elusive parasite.
    Baekby M, Glerup H, Stribolt K, Tarp B.
    BMJ Case Rep; 2017 Aug 16; 2017():. PubMed ID: 28814579
    [Abstract] [Full Text] [Related]

  • 17. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
    Webster BL, Diaw OT, Seye MM, Faye DS, Stothard JR, Sousa-Figueiredo JC, Rollinson D.
    Acta Trop; 2013 Nov 16; 128(2):292-302. PubMed ID: 23022016
    [Abstract] [Full Text] [Related]

  • 18. Two-year follow-up of Schistosoma mansoni infection and morbidity after treatment with different regimens of oxamniquine and praziquantel.
    Gryseels B, Nkulikyinka L.
    Trans R Soc Trop Med Hyg; 1989 Nov 16; 83(2):219-28. PubMed ID: 2514474
    [Abstract] [Full Text] [Related]

  • 19. Reduction of morbidity in hepatosplenic schistosomiasis mansoni after treatment with praziquantel: a long term study.
    Domingues AL, Coutinho AD.
    Rev Soc Bras Med Trop; 1990 Nov 16; 23(2):101-7. PubMed ID: 2129517
    [Abstract] [Full Text] [Related]

  • 20. Association of the therapeutic activity of praziquantel with the reversal of Symmers' fibrosis induced by Schistosoma mansoni.
    Homeida MA, el Tom I, Nash T, Bennett JL.
    Am J Trop Med Hyg; 1991 Sep 16; 45(3):360-5. PubMed ID: 1928571
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.